Exploratory biomarkers validation and sample analysis in any matrix or quantity. CMIC ensures biomarker results are accurate and reliable.
CMIC supports exploratory research to fully validated assays covering non-clinical and clinical studies. When reliable kits are not available, we develop robust in-house assays using vendor supplied antibodies to create assays. These assays are either singleplex or multiplex in design. We pride ourselves in meeting the challenges of the most stubborn of assays. Having measured over 50+ protein biomarkers in different matrices including serum, plasma, urine, blood cell, and tissue lysates, given that our scientists have over 20 years of experience in molecular biology and cell biology in key therapeutic areas, we believe we hold a decisive edge in helping you select the best biomarkers for your programs.
CMIC’s biomarker experience includes: fit-for-purpose method qualification, method transfer and development, full method validation and sample analysis.
| Analysis Platforms | Matrices | Therapeutic Areas |
| Chromatographic Ligand-binding assay Flow cytometry qPCR Enzyme assay |
Serum Plasma Urine Blood Cell Tissue |
Oncology Immuno-oncology Immunology Neurology |
